Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O C Boerman

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Critical Reviews in Therapeutic Drug Carrier Systems|January 16, 2002
In vivo applications of PEG liposomes: unexpected observationsP Laverman, O C Boerman, Oyen WJG, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|February 12, 1999
Liposomes for scintigraphic imaging: optimization of in vivo behaviorO C Boerman, W J Oyen, F H Corstens, et al.
British Journal of Cancer|March 1, 2002
(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumoursP Laverman, O C Boerman, G Storm, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
New concepts in infection/inflammation imagingH J Rennen, F H Corstens, W J Oyen, et al.
European Journal of Biochemistry|November 15, 1982
Primary gene products of bovine beta-crystallin and reassociation behavior of its aggregatesG A Berbers, O C Boerman, H Bloemendal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Absolute organ activity estimated by five different methods of background correctionW C Buijs, J A Siegel, O C Boerman, et al.
European Journal of Nuclear Medicine|April 17, 2001
Imaging infection/inflammation in the new millenniumH J Rennen, O C Boerman, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
A 3-step pretargeting strategy to image infectionO C Boerman, J van Eerd, W J Oyen, et al.
The British Journal of Surgery|March 2, 2005
Radioimmunotherapy and colorectal cancerM J Koppe, R P Bleichrodt, W J G Oyen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 1999
Absorption and biodistribution of 111indium-labelled desferrioxamine (111In-DFO) after subcutaneous injection of 111In-DFO liposomesN S Postma, O C Boerman, W J Oyen, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Critical Reviews in Therapeutic Drug Carrier Systems|January 16, 2002
In vivo applications of PEG liposomes: unexpected observationsP Laverman, O C Boerman, Oyen WJG, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|February 12, 1999
Liposomes for scintigraphic imaging: optimization of in vivo behaviorO C Boerman, W J Oyen, F H Corstens, et al.
British Journal of Cancer|March 1, 2002
(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumoursP Laverman, O C Boerman, G Storm, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
New concepts in infection/inflammation imagingH J Rennen, F H Corstens, W J Oyen, et al.
European Journal of Biochemistry|November 15, 1982
Primary gene products of bovine beta-crystallin and reassociation behavior of its aggregatesG A Berbers, O C Boerman, H Bloemendal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Absolute organ activity estimated by five different methods of background correctionW C Buijs, J A Siegel, O C Boerman, et al.
European Journal of Nuclear Medicine|April 17, 2001
Imaging infection/inflammation in the new millenniumH J Rennen, O C Boerman, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
A 3-step pretargeting strategy to image infectionO C Boerman, J van Eerd, W J Oyen, et al.
The British Journal of Surgery|March 2, 2005
Radioimmunotherapy and colorectal cancerM J Koppe, R P Bleichrodt, W J G Oyen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 1999
Absorption and biodistribution of 111indium-labelled desferrioxamine (111In-DFO) after subcutaneous injection of 111In-DFO liposomesN S Postma, O C Boerman, W J Oyen, et al.
Pageof 15